Connect with us

    Hi, what are you looking for?

    News

    Health Alert: NAFDAC Warns Against Use of Embacef 125 Suspension

    National Agency for Food and Drug Administration and Control (NAFDAC) has issued a recall notice for the antibiotic product Embacef 125 Powder for Oral Suspension, following safety complaints received from consumers.

    The recalled product, manufactured by Laborate Pharmaceutical India and registered in Nigeria by Embassy Pharmaceutical and Chemicals Ltd, Lagos, was reported to have caked or solidified after reconstitution by the second day of use. This complaint was brought to NAFDAC’s attention at its Ekiti State office, prompting a thorough investigation.

    NAFDAC’s findings confirmed the product’s substandard quality and potential health risks associated with its use. As a precautionary measure, the agency has mandated a recall of the affected batch, identified by batch number PEDSE001, manufactured in February 2025 and expiring in January 2027.

    Embacef 125 contains Cefuroxime Axetil, an antibiotic used to treat a variety of bacterial infections such as bronchitis, gonorrhea, Lyme disease, and infections of the skin, ears, sinuses, throat, tonsils, and urinary tract.

    The agency warned that using substandard antibiotics could worsen patient conditions, lead to treatment failures, and contribute to the emergence of antibiotic-resistant bacteria.

    NAFDAC has directed all zonal directors and state coordinators to intensify surveillance activities and remove the affected products from circulation. The public has been urged to purchase medicines only from authorized and licensed suppliers and to verify product authenticity and physical condition before use.

    Consumers and healthcare professionals are encouraged to report any suspected cases of substandard medicines or adverse effects via NAFDAC’s hotline, email, or the Med-Safety App.

    The recall notification has also been shared internationally through the World Health Organisation’s Global Surveillance and Monitoring System to enhance global tracking and intervention efforts.

    This swift action by NAFDAC underscores the agency’s commitment to safeguarding public health and ensuring the availability of safe, effective medicines in Nigeria.

    Spread the love
    Click to comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    ad

    You May Also Like

    E-Financial

    Polaris Bank, Nigeria’s leading digital retail, and commercial bank, on Tuesday hosted corporate customers in the non-oil sector at its Global Trade Forum. The...

    News

    Bill Gates, Chair of the Bill & Melinda Gates Foundation, has called on global leaders to make bold choices that could save millions of...

    News

    President Bola Tinubu has declared Nigeria’s ambition to host the 2030 Commonwealth Games a “dream” that must be realised, urging the international sporting body...

    News

    South Korea has opened a criminal trial for Kim Keon Hee, the wife of impeached former president Yoon Suk Yeol, marking the first time...